Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 2/20 | 0.32 |
| ▸ | PTGDR2 | Q9Y5Y4 | 4/20 | 0.31 |
| ▸ | S1PR1 | P21453 | 4/20 | 0.31 |
| ▸ | SGPL1 | O95470 | 1/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.31 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.31 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.31 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13328589 | 0.83 | ACHE (0.33) | ACHE | |
| SCHEMBL13328646 | 0.76 | ALDH1A1 (0.34) | — | |
| SCHEMBL1311479 | 0.75 | RIPK1 (0.38) | KDM1APTGDR2 | |
| SCHEMBL13328555 | 0.74 | TLR4 (0.34) | ACHE | |
| SCHEMBL13378230 | 0.73 | NPC1 (0.34) | KDM1A | |
| SCHEMBL31722819 | 0.73 | NPC1 (0.34) | KDM1A | |
| SCHEMBL6402937 | 0.73 | FYN (0.36) | S1PR1SGPL1 | |
| SCHEMBL18084735 | 0.72 | HTR1D (0.37) | S1PR3 | |
| SCHEMBL12433700 | 0.72 | KDM1A (0.32) | KDM1AESR1 | |
| SCHEMBL11917052 | 0.72 | FPR2 (0.35) | KDM1AS1PR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050133762-A1 | Liquid crystalline compound having high optical anisotropy and liquid crystalline composition comprising the same | SAMSUNG ELECTRONIC CO., LTD. (KR) | 2005-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050133762-A1 | Liquid crystalline compound having high optical anisotropy and liquid crystalline composition comprising the same | KIF23, CDK13, KIF11 | KDM1A 3674/4885PTGDR2 3592/4885S1PR1 1860/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.